2023 Form 5500 filing — Alnylam Pharmaceuticals, Inc. Consolidated Welfare Benefits Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240613173656NAL0014801107001) for Alnylam Pharmaceuticals, Inc. Consolidated Welfare Benefits Plan, reported by Alnylam Pharmaceuticals, Inc. under EIN 04-3696884 and plan number 501. It reports 1,604 participants. Attached schedule details are not reported in the loaded dataset.
- EFAST2 acknowledgement
- 20240613173656NAL0014801107001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Alnylam Pharmaceuticals, Inc.
- EIN
- 04-3696884
- Plan number
- 501
- Location
- Cambridge, MA
- Participants
- 1,604
- Schedules available
- Not reported in the loaded dataset
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
This 2023 filing is loaded, but detailed Schedule H/I financial figures are not present for it in the current loaded dataset. Participant counts and filing identity above are reported; asset and contribution detail comes from the financial schedules where filed.